HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of a single dose of mebendazole on prevalence and intensity of soil-transmitted nematodes in Zanzibar.

Abstract
The efficacy of a single-dose of mebendazole to treat intestinal helminths was studied in Pemba Island, Zanzibar, with the view of incorporating it in future control programmes. A single Kato-Katz stool examination was performed on 2,269 individuals from all age groups. 1,883 individuals were treated with 500 mg of mebendazole (250 mg for children below two years) and re-examined one month and four months after therapy. A total of 466 presented themselves for all three surveys and the data has been reported in this study. The overall cure rate for ascariasis was 93.2% and reduction of egg load after treatment was 89.8% in persistent positive cases. Although the cure rates were lower in trichuriasis (25.6%) and hookworm (17.8%) infections, egg reduction was more evident with 47% for Trichuris trichiura and 51.9% for hookworms. A single dose of mebendazole results not only in a high cure rate for ascariasis but also in a decrease in intensity of ascariasis, trichuriasis and hookworm infections, thereby contributing to its incorporation into low-budget control programmes in developing countries.
AuthorsM Albonico, E Renganathan, A Bosman, U M Kisumku, K S Alawi, L Savioli
JournalTropical and geographical medicine (Trop Geogr Med) Vol. 46 Issue 3 Pg. 142-6 ( 1994) ISSN: 0041-3232 [Print] Netherlands
PMID7941002 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Mebendazole
Topics
  • Adolescent
  • Adult
  • Ascariasis (epidemiology, parasitology, prevention & control)
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Hookworm Infections (epidemiology, parasitology, prevention & control)
  • Humans
  • Infant
  • Infant, Newborn
  • Mebendazole (therapeutic use)
  • Prevalence
  • Tanzania (epidemiology)
  • Treatment Outcome
  • Trichuriasis (epidemiology, parasitology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: